Pathological features and prognostication in colorectal cancer
The prognostication of colorectal cancer (CRC) has traditionally relied on staging as defined
by the Union for International Cancer Control (UICC) and American Joint Committee on …
by the Union for International Cancer Control (UICC) and American Joint Committee on …
[HTML][HTML] Different treatment strategies and molecular features between right-sided and left-sided colon cancers
H Shen, J Yang, Q Huang, MJ Jiang… - World journal of …, 2015 - ncbi.nlm.nih.gov
The colon is derived from the embryological midgut and hindgut separately, with the right
colon and left colon having different features with regards to both anatomical and …
colon and left colon having different features with regards to both anatomical and …
Comparison of oncological outcomes of right-sided colon cancer versus left-sided colon cancer after curative resection: which side is better outcome?
DR Lim, JK Kuk, T Kim, EJ Shin - Medicine, 2017 - journals.lww.com
Results: On average, RCC exhibited a more advanced N stage, increased tumor size, more
frequently poorly differentiated tumors, more harvested lymph nodes, and more positivity of …
frequently poorly differentiated tumors, more harvested lymph nodes, and more positivity of …
Microsatellite instability and survival in stage II colorectal cancer: a systematic review and meta-analysis
F Petrelli, M Ghidini, M Cabiddu, E Pezzica… - Anticancer …, 2019 - ar.iiarjournals.org
Background/Aim: About 15-20% of colorectal cancers (CRCs) have deficiency in a mismatch
repair (MMR) protein. MMR has a high level of microsatellite instability (MSI-H). We have …
repair (MMR) protein. MMR has a high level of microsatellite instability (MSI-H). We have …
Distinguishable prognostic signatures of left-and right-sided colon cancer: a study based on sequencing data
L Liang, J Zeng, X Qin, J Chen, D Luo… - Cellular Physiology and …, 2018 - karger.com
Abstract Background/Aims: Left-and right-sided colon cancers are considered to be two
different diseases and have altered outcomes. However, specific molecules to predict the …
different diseases and have altered outcomes. However, specific molecules to predict the …
[HTML][HTML] Comparison of microsatellite status detection methods in colorectal carcinoma
ML Chen, JY Chen, J Hu, Q Chen, LX Yu… - … Journal of Clinical …, 2018 - ncbi.nlm.nih.gov
There are two commonly accepted methods for detecting microsatellite status. One is to
detect amplified microsatellite loci by polymerase chain reaction (PCR) and the other is to …
detect amplified microsatellite loci by polymerase chain reaction (PCR) and the other is to …
Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis
JWT Toh, K Phan, F Reza, P Chapuis… - International Journal of …, 2021 - Springer
Introduction For the past two decades, microsatellite instability (MSI) has been reported as a
robust clinical biomarker associated with survival advantage attributed to its immunogenicity …
robust clinical biomarker associated with survival advantage attributed to its immunogenicity …
Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer
HM Mohan, E Ryan, I Balasubramanian… - European Journal of …, 2016 - Elsevier
Background Up to 15% of colorectal cancers exhibit microsatellite instability (MSI), where
errors in replication go unchecked due to defects in the mismatch repair system. This study …
errors in replication go unchecked due to defects in the mismatch repair system. This study …
Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location
Background MicroRNAs (miRNA) and other small RNAs are frequently dysregulated in
cancer and are promising biomarkers for colon cancer. Here we profile human, virus and …
cancer and are promising biomarkers for colon cancer. Here we profile human, virus and …
[HTML][HTML] Downregulation of acetyl-CoA synthetase 2 is a metabolic hallmark of tumor progression and aggressiveness in colorectal carcinoma
JM Bae, JH Kim, HJ Oh, HE Park, TH Lee, NY Cho… - Modern Pathology, 2017 - Elsevier
Acetyl-CoA synthetase-2 is an emerging key enzyme for cancer metabolism, which supplies
acetyl-CoA for tumor cells by capturing acetate as a carbon source under stressed …
acetyl-CoA for tumor cells by capturing acetate as a carbon source under stressed …